Ignite Creation Date:
2024-05-06 @ 8:06 AM
Last Modification Date:
2024-10-26 @ 11:56 AM
Study NCT ID:
NCT02668653
Status:
COMPLETED
Last Update Posted:
2023-11-18
First Post:
2016-01-22
Brief Title:
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD Acute Myeloid Leukemia AML
Sponsor:
Daiichi Sankyo
Organization:
Daiichi Sankyo
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |
| Acute Myeloid Leukemia |